Zoekresultaten - 5 results
Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
Publication Type: Peer reviewed scientific article Authors: Goossens, Martine; Katia Pauwels; Nicolas Willemarck; Didier Breyer Source: Curr Gene Ther, Volume 13, Issue 6, p.413-20 (2013) Keywords: ...
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.
Publication Type: Peer reviewed scientific article Authors: Verheust, Céline; Goossens, Martine; Katia Pauwels; Didier Breyer Source: Vaccine, Volume 30, Issue 16, p.2623-32 (2012) Keywords: Animals ...
State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.
Publication Type: Peer reviewed scientific article Authors: Katia Pauwels; Gijsbers, Rik; Toelen, Jaan; Schambach, Axel; Willard-Gallo, Karen; Verheust, Céline; Debyser, Zeger; Philippe Herman ...
Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation
Pauwels; Myriam Sneyers; Reheul,D. Source: ISB news report, ISBN, Volume November 2009, Number 12, Brussels, p.2- 12 (2009) Keywords: EU mutagenesis New techniques Paper regulation Regulatory SAFETY SBB ...
Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?
Custers, René; Katia Pauwels; Myriam Sneyers; Reheul, Dirk Source: Environ Biosafety Res, Volume 8, Issue 2, p.57-64 (2009) Keywords: Animals Animals, Genetically Modified European Union genetic engineering ...